Nachrichten zur Pfizer Inc. Aktie

Doctor Calls For Withdrawal Of Pfizer, Moderna COVID-19 Vaccines Following New Research

Doctor Calls For Withdrawal Of Pfizer, Moderna COVID-19 Vaccines Following New Research …

CDC Says Stroke Concerns Over Pfizer Jab Warrant Investigation

CDC Says Stroke Concerns Over Pfizer Jab Warrant Investigation …

Pfizer BioNTech Covid-19 Bivalent Vaccine And Strokes: What You Need To Know

Theres been a lot of chatter about the January 13 announcement from the Centers for Disease Control and Prevention (CDC)…

Pfizer Bivalent Vaccine Linked to Strokes in Preliminary Data

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer Bivalent Vaccine Linked to Stroke in Preliminary Data

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer COVID-19 shot safety signal in seniors under investigation by CDC, FDA

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Lilly (LLY), Pfizer (PFE), Amgen (AMGN) Crowd Into Hot Obesity ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ursula von der Leyen, at the center of the controversy over the contracts with Pfizer

By Carlos Esteban* The principle that citizens, like impressionable infants with limited intelligence, have no right to know the intricacies…

Autoimmune Patient Perspective on the Corporate Reputation of Pharma Companies, 2021-2022: The Views of 293 Patient Groups - Pfizer Ranked 1st, AbbVie Ranked 2nd, Novartis Ranked 3rd

DUBLIN, Jan. 13, 2023 /PRNewswire/ -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition…

Daiichi Sankyo Applies for COVID-19 Vaccine Approval

Tokyo, Jan. 13 (Jiji Press)--Daiichi Sankyo Co. said Friday it has applied for health ministry approval for a COVID-19…

Patient Perspective of the Corporate Reputation of Pharma Companies, 2021-2022: Boehringer Ingelheim Ranked 1st, Sanofi 2nd and Pfizer Ranked 3rd

DUBLIN, Jan. 13, 2023 /PRNewswire/ -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory…

Corporate Reputation of Pharma Companies in United States, 2021-2022: The Views of 240 Patient Groups - ViiV Healthcare Ranked 1st, Horizon Therapeutics Ranked 2nd and Pfizer Ranked 3rd

DUBLIN, Jan. 13, 2023 /PRNewswire/ -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - USA…

Deadline Passes For Pfizer To Submit Results Of Post-Vaccination Heart Inflammation Study To US Regulators

Deadline Passes For Pfizer To Submit Results Of Post-Vaccination Heart Inflammation Study To US Regulators …

Supreme Court declines to hear Pfizer case on financial assistance to Medicare enrollees

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer: Hoffnung auf weltweit ersten RSV-Impfstoff - Aktienanalyse

Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse von der Raiffeisen Bank International AG: Benedikt-Luka Antic, Analyst der Raiffeisen Bank International AG (RBI), rät in…

Pfizer director used exclusive channel to ask Twitter to censor Covid-19 vaccine skeptics

In yet another release of Twitter insider information by new owner Elon Musk, reporter Alex Berenson reported on Jan. 9…

Chinese health expert: local production of Paxlovid should be able to start soon

...BEIJING (Reuters) - Supplies of Pfizers Paxlovid in China......…

Hewlett Packard Enterprise adds former Pfizer CFO to its board

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know

Pfizer (PFE) closed at $47.62 in the latest trading session, marking a -1.59% move from the prior day....…

HPE appoints former Pfizer CFO DAmelio to board

Hewlett Packard Enterprise Co. on Tuesday appointed Frank D'Amelio, former chief financial officer of Pfizer Inc. , to HPE's…

Thinking about trading options or stock in TD Synnex, Apple, Pfizer, Advanced Micro Devices, or Verizon?

NEW YORK, Jan. 10, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNX, AAPL, PFE, AMD, and VZ. Click…

Pfizer CEO Dismisses Reports of a Paxlovid Generic for China

Whats new: Pfizer Inc. CEO Albert Bourla shot down reports that the pharmaceutical giant is working with a company in…

Stocks Slip Lower, Powell Speech, Pfizer Oak Street, Microsoft - Five Things To Know

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer says in talks with China over pricing of Covid pill

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer in talks with China over pricing of Covid pill

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

FDA Deviated From Normal Process In Pfizer Vaccine Approval, Documents Show

FDA Deviated From Normal Process In Pfizer Vaccine Approval, Documents Show …

UPDATE 1-Pfizer CEO says there will be no generic Paxlovid for China

...(Adds details from CEO Bourla) Jan 9 (Reuters) - Pfizer Inc... on Monday. Reuters reported on Friday that China was in talks…

Pfizer Says Partner in China Is Gearing up for Paxlovid Sales

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer not in talks on licensing generic COVID pill in China

...NEW YORK (Reuters) - Pfizer Inc Chief Executive Albert Bourla......…

This Censorious Pfizer Board Member Was A Major Influence On Lockdowns

This Censorious Pfizer Board Member Was A Major Influence On Lockdowns …

Pfizer projects up to $84B non COVID revenue in 2030

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Arvinas falls 17% after early-stage data for Pfizer-partnered tumor therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer working to send COVID pill Paxlovid to China - CNBC

...(Reuters) - Pfizer Inc is working with Chinese authorities... to a Reuters request for comment on…

Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly

Israel based real-world study shows that omicron-targeted COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) reduced hospitalizations among older patients. read…

UPDATE 1-U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication

... (Reuters) - The U.S. Supreme Court on Monday turned away Pfizer Incs......…

U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication

...WASHINGTON (Reuters) - The U.S. Supreme Court on Monday turned......…

This Stock Could Be a Surprise Growth Pick for 2023

Pfizer is about to enter a whole new era of growth....…

Pfizer Rejected by CN Medical Insurance Drug Catalogue due to High Price; CN in Talks About Producing Paxlovid Generic Drug

The negotiation on the 2022 National Medical Insurance Drug Catalogue has officially concluded yesterday (8th), China's National Healthcare Security Administration…

It’s Pharma Time: Why Merck and Lilly Are Buys, but Not Pfizer.

With rates rising, biotech has faded. Investors have favored the pharma stalwarts. Bank of America’s drug analyst Geoff Meacham runs…

Exclusive-China in talks with Pfizer for generic COVID drug - sources

...By Julie Zhu and Kevin Huang HONG KONG/BEIJING (Reuters) - China... told Reuters. Chinas medical products regulator -…

Pfizer, China in discussions to license to generic version of COVID drug Paxlovid

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Cancer Vaccine Trials—Using Same mRNA Tech Behind Covid Shots—Could Launch In U.K. This September

BioNTech, which worked with Pfizer to build an mRNA Covid vaccine, has partnered with the U.K. to turn the technology…

Pfizer Gets FDA Priority Review of Prevnar 20 for Kids >PFE

Pfizer Gets FDA Priority Review of Prevnar 20 for Kids >PFE...…

UPDATE 1-Pfizer to scale down early-stage rare disease research

...(Changes source, adds Pfizer statement) Jan 5 (Reuters) - U.S. pharma... disease and oncology," a spokesperson said in a statement to Reuters,…

BRIEF-Pfizer Says It Will Be Shifting To Invest In Rare And Benign Hematology And Platforms Such As Gene Editing Through External Innovation On Rare Conditions

...Jan 5 (Reuters) - * PFIZER SAYS WILL BE SHIFTING TO INVEST IN RARE......…

Pfizer could sell some assets, convert others into new companies amid broader refocus

Drug maker Pfizer Inc. could part with or otherwise distance itself from some of its research programs....…

Pfizer to Pull Back on Research Into Rare Disease, Gene Therapy

As part of the shift, the company may sell assets like its gene therapy facility in Durham and a cancer-focused…

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

Thursday’s Top Analyst Upgrades and Downgrades: Baidu, BNY Mellon, Corning, Merck, Meta Platforms, Microsoft, Pfizer, Rivian, Target and More

Thursdays top analyst upgrades and downgrades included Baidu, Bank of New York Mellon, Charles Schwab, Corning, Livent, Merck, Meta Platforms,…

Wegen Impf-Flaute - Dermapharm am unteren Ende der Erwartungen

München (Reuters) - Die stark abflauende Nachfrage nach Corona-Impfstoff setzt dem Arzneimittel-Hersteller Dermapharm zu.

Das Unternehmen aus Grünwald bei München…